Atea Pharmaceuticals Inc (AVIR) — Cash Flow Reinvestment Rate
Atea Pharmaceuticals Inc (AVIR) has a Cash Flow Reinvestment Rate of 0.00x as of September 2021, reinvesting $4.00K (capex $4.00K ) from operating cash flow of $22.60 Million. Explore Atea Pharmaceuticals Inc (AVIR) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Atea Pharmaceuticals Inc Cash Flow Reinvestment Rate (2020–2020)
Historical reinvestment intensity for Atea Pharmaceuticals Inc across 1 annual periods. Also explore Atea Pharmaceuticals Inc (AVIR) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Atea Pharmaceuticals Inc (2020–2020)
Year-by-year capital reinvestment analysis for Atea Pharmaceuticals Inc. For live market cap and broader valuation context, see market value of Atea Pharmaceuticals Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.00x | $52.00K | $296.73 Million | $26.00K | — |